Insomnia Medication Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Aluminum Silver Paint in global, including the following market information:
Global Aluminum Silver Paint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aluminum Silver Paint Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Aluminum Silver Paint companies in 2021 (%)
The global Aluminum Silver Paint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alkyd Based Aluminum Silver Paint Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aluminum Silver Paint include AkzoNobel, Jotun, CMP, BASF, Sherwin-Williams, HEMPEL, Nippon Paint and Kansai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aluminum Silver Paint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aluminum Silver Paint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Aluminum Silver Paint Market Segment Percentages, by Type, 2021 (%)
Global Aluminum Silver Paint Market Segment Percentages, by Application, 2021 (%)
Global Aluminum Silver Paint Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Aluminum Silver Paint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aluminum Silver Paint revenues share in global market, 2021 (%)
Key companies Aluminum Silver Paint sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Aluminum Silver Paint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Aluminum Silver Paint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aluminum Silver Paint Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Aluminum Silver Paint companies in 2021 (%)
The global Aluminum Silver Paint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alkyd Based Aluminum Silver Paint Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aluminum Silver Paint include AkzoNobel, Jotun, CMP, BASF, Sherwin-Williams, HEMPEL, Nippon Paint and Kansai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aluminum Silver Paint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aluminum Silver Paint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Aluminum Silver Paint Market Segment Percentages, by Type, 2021 (%)
- Alkyd Based Aluminum Silver Paint
- Silicone Based Aluminum Silver Paint
Global Aluminum Silver Paint Market Segment Percentages, by Application, 2021 (%)
- Ship & Offshore
- Automotive
- Power
- Others
Global Aluminum Silver Paint Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Aluminum Silver Paint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aluminum Silver Paint revenues share in global market, 2021 (%)
Key companies Aluminum Silver Paint sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Aluminum Silver Paint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AkzoNobel
- Jotun
- CMP
- BASF
- Sherwin-Williams
- HEMPEL
- Nippon Paint
- Kansai
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Insomnia Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSOMNIA MEDICATION OVERALL MARKET SIZE
2.1 Global Insomnia Medication Market Size: 2021 VS 2028
2.2 Global Insomnia Medication Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Insomnia Medication Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Insomnia Medication Players in Global Market
3.2 Top Global Insomnia Medication Companies Ranked by Revenue
3.3 Global Insomnia Medication Revenue by Companies
3.4 Global Insomnia Medication Sales by Companies
3.5 Global Insomnia Medication Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Insomnia Medication Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Insomnia Medication Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insomnia Medication Players in Global Market
3.8.1 List of Global Tier 1 Insomnia Medication Companies
3.8.2 List of Global Tier 2 and Tier 3 Insomnia Medication Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insomnia Medication Market Size Markets, 2021 & 2028
4.1.2 Nonbenzodiazepine Receptor Agonists
4.1.3 Benzodiazepine Receptor Agonists
4.1.4 The Selective Melatonin Receptor Agonist Ramelteon
4.1.5 Sedating Antidepressants
4.2 By Type - Global Insomnia Medication Revenue & Forecasts
4.2.1 By Type - Global Insomnia Medication Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Medication Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Medication Revenue Market Share, 2017-2028
4.3 By Type - Global Insomnia Medication Sales & Forecasts
4.3.1 By Type - Global Insomnia Medication Sales, 2017-2022
4.3.2 By Type - Global Insomnia Medication Sales, 2023-2028
4.3.3 By Type - Global Insomnia Medication Sales Market Share, 2017-2028
4.4 By Type - Global Insomnia Medication Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insomnia Medication Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Kids
5.2 By Application - Global Insomnia Medication Revenue & Forecasts
5.2.1 By Application - Global Insomnia Medication Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Medication Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Medication Revenue Market Share, 2017-2028
5.3 By Application - Global Insomnia Medication Sales & Forecasts
5.3.1 By Application - Global Insomnia Medication Sales, 2017-2022
5.3.2 By Application - Global Insomnia Medication Sales, 2023-2028
5.3.3 By Application - Global Insomnia Medication Sales Market Share, 2017-2028
5.4 By Application - Global Insomnia Medication Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Insomnia Medication Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Medication Revenue & Forecasts
6.2.1 By Region - Global Insomnia Medication Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Medication Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Medication Revenue Market Share, 2017-2028
6.3 By Region - Global Insomnia Medication Sales & Forecasts
6.3.1 By Region - Global Insomnia Medication Sales, 2017-2022
6.3.2 By Region - Global Insomnia Medication Sales, 2023-2028
6.3.3 By Region - Global Insomnia Medication Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Insomnia Medication Revenue, 2017-2028
6.4.2 By Country - North America Insomnia Medication Sales, 2017-2028
6.4.3 US Insomnia Medication Market Size, 2017-2028
6.4.4 Canada Insomnia Medication Market Size, 2017-2028
6.4.5 Mexico Insomnia Medication Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Insomnia Medication Revenue, 2017-2028
6.5.2 By Country - Europe Insomnia Medication Sales, 2017-2028
6.5.3 Germany Insomnia Medication Market Size, 2017-2028
6.5.4 France Insomnia Medication Market Size, 2017-2028
6.5.5 U.K. Insomnia Medication Market Size, 2017-2028
6.5.6 Italy Insomnia Medication Market Size, 2017-2028
6.5.7 Russia Insomnia Medication Market Size, 2017-2028
6.5.8 Nordic Countries Insomnia Medication Market Size, 2017-2028
6.5.9 Benelux Insomnia Medication Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Insomnia Medication Revenue, 2017-2028
6.6.2 By Region - Asia Insomnia Medication Sales, 2017-2028
6.6.3 China Insomnia Medication Market Size, 2017-2028
6.6.4 Japan Insomnia Medication Market Size, 2017-2028
6.6.5 South Korea Insomnia Medication Market Size, 2017-2028
6.6.6 Southeast Asia Insomnia Medication Market Size, 2017-2028
6.6.7 India Insomnia Medication Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Insomnia Medication Revenue, 2017-2028
6.7.2 By Country - South America Insomnia Medication Sales, 2017-2028
6.7.3 Brazil Insomnia Medication Market Size, 2017-2028
6.7.4 Argentina Insomnia Medication Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insomnia Medication Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Insomnia Medication Sales, 2017-2028
6.8.3 Turkey Insomnia Medication Market Size, 2017-2028
6.8.4 Israel Insomnia Medication Market Size, 2017-2028
6.8.5 Saudi Arabia Insomnia Medication Market Size, 2017-2028
6.8.6 UAE Insomnia Medication Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eisai
7.1.1 Eisai Corporate Summary
7.1.2 Eisai Business Overview
7.1.3 Eisai Insomnia Medication Major Product Offerings
7.1.4 Eisai Insomnia Medication Sales and Revenue in Global (2017-2022)
7.1.5 Eisai Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Insomnia Medication Major Product Offerings
7.2.4 Merck Insomnia Medication Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Medication Major Product Offerings
7.3.4 Pfizer Insomnia Medication Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Insomnia Medication Major Product Offerings
7.4.4 Sanofi Insomnia Medication Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Insomnia Medication Major Product Offerings
7.5.4 Takeda Insomnia Medication Sales and Revenue in Global (2017-2022)
7.5.5 Takeda Key News
7.6 Vanda Pharmaceuticals
7.6.1 Vanda Pharmaceuticals Corporate Summary
7.6.2 Vanda Pharmaceuticals Business Overview
7.6.3 Vanda Pharmaceuticals Insomnia Medication Major Product Offerings
7.6.4 Vanda Pharmaceuticals Insomnia Medication Sales and Revenue in Global (2017-2022)
7.6.5 Vanda Pharmaceuticals Key News
7.7 Astellas
7.7.1 Astellas Corporate Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Insomnia Medication Major Product Offerings
7.7.4 Astellas Insomnia Medication Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Key News
7.8 Dainippon Sumitomo
7.8.1 Dainippon Sumitomo Corporate Summary
7.8.2 Dainippon Sumitomo Business Overview
7.8.3 Dainippon Sumitomo Insomnia Medication Major Product Offerings
7.8.4 Dainippon Sumitomo Insomnia Medication Sales and Revenue in Global (2017-2022)
7.8.5 Dainippon Sumitomo Key News
7.9 ECR Pharmaceuticals (Valeant)
7.9.1 ECR Pharmaceuticals (Valeant) Corporate Summary
7.9.2 ECR Pharmaceuticals (Valeant) Business Overview
7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Major Product Offerings
7.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales and Revenue in Global (2017-2022)
7.9.5 ECR Pharmaceuticals (Valeant) Key News
7.10 Flynn Pharma
7.10.1 Flynn Pharma Corporate Summary
7.10.2 Flynn Pharma Business Overview
7.10.3 Flynn Pharma Insomnia Medication Major Product Offerings
7.10.4 Flynn Pharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.10.5 Flynn Pharma Key News
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporate Summary
7.11.2 Johnson & Johnson Insomnia Medication Business Overview
7.11.3 Johnson & Johnson Insomnia Medication Major Product Offerings
7.11.4 Johnson & Johnson Insomnia Medication Sales and Revenue in Global (2017-2022)
7.11.5 Johnson & Johnson Key News
7.12 Meda
7.12.1 Meda Corporate Summary
7.12.2 Meda Insomnia Medication Business Overview
7.12.3 Meda Insomnia Medication Major Product Offerings
7.12.4 Meda Insomnia Medication Sales and Revenue in Global (2017-2022)
7.12.5 Meda Key News
7.13 Somnus Therapeutics
7.13.1 Somnus Therapeutics Corporate Summary
7.13.2 Somnus Therapeutics Insomnia Medication Business Overview
7.13.3 Somnus Therapeutics Insomnia Medication Major Product Offerings
7.13.4 Somnus Therapeutics Insomnia Medication Sales and Revenue in Global (2017-2022)
7.13.5 Somnus Therapeutics Key News
7.14 Purdue Pharma
7.14.1 Purdue Pharma Corporate Summary
7.14.2 Purdue Pharma Business Overview
7.14.3 Purdue Pharma Insomnia Medication Major Product Offerings
7.14.4 Purdue Pharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.14.5 Purdue Pharma Key News
7.15 Neurim
7.15.1 Neurim Corporate Summary
7.15.2 Neurim Business Overview
7.15.3 Neurim Insomnia Medication Major Product Offerings
7.15.4 Neurim Insomnia Medication Sales and Revenue in Global (2017-2022)
7.15.5 Neurim Key News
7.16 Minerva Neurosciences
7.16.1 Minerva Neurosciences Corporate Summary
7.16.2 Minerva Neurosciences Business Overview
7.16.3 Minerva Neurosciences Insomnia Medication Major Product Offerings
7.16.4 Minerva Neurosciences Insomnia Medication Sales and Revenue in Global (2017-2022)
7.16.5 Minerva Neurosciences Key News
7.17 Pernix Therapeutics
7.17.1 Pernix Therapeutics Corporate Summary
7.17.2 Pernix Therapeutics Business Overview
7.17.3 Pernix Therapeutics Insomnia Medication Major Product Offerings
7.17.4 Pernix Therapeutics Insomnia Medication Sales and Revenue in Global (2017-2022)
7.17.5 Pernix Therapeutics Key News
7.18 SkyePharma
7.18.1 SkyePharma Corporate Summary
7.18.2 SkyePharma Business Overview
7.18.3 SkyePharma Insomnia Medication Major Product Offerings
7.18.4 SkyePharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.18.5 SkyePharma Key News
7.19 Paratek Pharmaceuticals
7.19.1 Paratek Pharmaceuticals Corporate Summary
7.19.2 Paratek Pharmaceuticals Business Overview
7.19.3 Paratek Pharmaceuticals Insomnia Medication Major Product Offerings
7.19.4 Paratek Pharmaceuticals Insomnia Medication Sales and Revenue in Global (2017-2022)
7.19.5 Paratek Pharmaceuticals Key News
8 GLOBAL INSOMNIA MEDICATION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insomnia Medication Production Capacity, 2017-2028
8.2 Insomnia Medication Production Capacity of Key Manufacturers in Global Market
8.3 Global Insomnia Medication Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSOMNIA MEDICATION SUPPLY CHAIN ANALYSIS
10.1 Insomnia Medication Industry Value Chain
10.2 Insomnia Medication Upstream Market
10.3 Insomnia Medication Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insomnia Medication Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Insomnia Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSOMNIA MEDICATION OVERALL MARKET SIZE
2.1 Global Insomnia Medication Market Size: 2021 VS 2028
2.2 Global Insomnia Medication Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Insomnia Medication Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Insomnia Medication Players in Global Market
3.2 Top Global Insomnia Medication Companies Ranked by Revenue
3.3 Global Insomnia Medication Revenue by Companies
3.4 Global Insomnia Medication Sales by Companies
3.5 Global Insomnia Medication Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Insomnia Medication Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Insomnia Medication Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insomnia Medication Players in Global Market
3.8.1 List of Global Tier 1 Insomnia Medication Companies
3.8.2 List of Global Tier 2 and Tier 3 Insomnia Medication Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insomnia Medication Market Size Markets, 2021 & 2028
4.1.2 Nonbenzodiazepine Receptor Agonists
4.1.3 Benzodiazepine Receptor Agonists
4.1.4 The Selective Melatonin Receptor Agonist Ramelteon
4.1.5 Sedating Antidepressants
4.2 By Type - Global Insomnia Medication Revenue & Forecasts
4.2.1 By Type - Global Insomnia Medication Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Medication Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Medication Revenue Market Share, 2017-2028
4.3 By Type - Global Insomnia Medication Sales & Forecasts
4.3.1 By Type - Global Insomnia Medication Sales, 2017-2022
4.3.2 By Type - Global Insomnia Medication Sales, 2023-2028
4.3.3 By Type - Global Insomnia Medication Sales Market Share, 2017-2028
4.4 By Type - Global Insomnia Medication Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insomnia Medication Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Kids
5.2 By Application - Global Insomnia Medication Revenue & Forecasts
5.2.1 By Application - Global Insomnia Medication Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Medication Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Medication Revenue Market Share, 2017-2028
5.3 By Application - Global Insomnia Medication Sales & Forecasts
5.3.1 By Application - Global Insomnia Medication Sales, 2017-2022
5.3.2 By Application - Global Insomnia Medication Sales, 2023-2028
5.3.3 By Application - Global Insomnia Medication Sales Market Share, 2017-2028
5.4 By Application - Global Insomnia Medication Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Insomnia Medication Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Medication Revenue & Forecasts
6.2.1 By Region - Global Insomnia Medication Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Medication Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Medication Revenue Market Share, 2017-2028
6.3 By Region - Global Insomnia Medication Sales & Forecasts
6.3.1 By Region - Global Insomnia Medication Sales, 2017-2022
6.3.2 By Region - Global Insomnia Medication Sales, 2023-2028
6.3.3 By Region - Global Insomnia Medication Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Insomnia Medication Revenue, 2017-2028
6.4.2 By Country - North America Insomnia Medication Sales, 2017-2028
6.4.3 US Insomnia Medication Market Size, 2017-2028
6.4.4 Canada Insomnia Medication Market Size, 2017-2028
6.4.5 Mexico Insomnia Medication Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Insomnia Medication Revenue, 2017-2028
6.5.2 By Country - Europe Insomnia Medication Sales, 2017-2028
6.5.3 Germany Insomnia Medication Market Size, 2017-2028
6.5.4 France Insomnia Medication Market Size, 2017-2028
6.5.5 U.K. Insomnia Medication Market Size, 2017-2028
6.5.6 Italy Insomnia Medication Market Size, 2017-2028
6.5.7 Russia Insomnia Medication Market Size, 2017-2028
6.5.8 Nordic Countries Insomnia Medication Market Size, 2017-2028
6.5.9 Benelux Insomnia Medication Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Insomnia Medication Revenue, 2017-2028
6.6.2 By Region - Asia Insomnia Medication Sales, 2017-2028
6.6.3 China Insomnia Medication Market Size, 2017-2028
6.6.4 Japan Insomnia Medication Market Size, 2017-2028
6.6.5 South Korea Insomnia Medication Market Size, 2017-2028
6.6.6 Southeast Asia Insomnia Medication Market Size, 2017-2028
6.6.7 India Insomnia Medication Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Insomnia Medication Revenue, 2017-2028
6.7.2 By Country - South America Insomnia Medication Sales, 2017-2028
6.7.3 Brazil Insomnia Medication Market Size, 2017-2028
6.7.4 Argentina Insomnia Medication Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insomnia Medication Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Insomnia Medication Sales, 2017-2028
6.8.3 Turkey Insomnia Medication Market Size, 2017-2028
6.8.4 Israel Insomnia Medication Market Size, 2017-2028
6.8.5 Saudi Arabia Insomnia Medication Market Size, 2017-2028
6.8.6 UAE Insomnia Medication Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Eisai
7.1.1 Eisai Corporate Summary
7.1.2 Eisai Business Overview
7.1.3 Eisai Insomnia Medication Major Product Offerings
7.1.4 Eisai Insomnia Medication Sales and Revenue in Global (2017-2022)
7.1.5 Eisai Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Insomnia Medication Major Product Offerings
7.2.4 Merck Insomnia Medication Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Medication Major Product Offerings
7.3.4 Pfizer Insomnia Medication Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Insomnia Medication Major Product Offerings
7.4.4 Sanofi Insomnia Medication Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Insomnia Medication Major Product Offerings
7.5.4 Takeda Insomnia Medication Sales and Revenue in Global (2017-2022)
7.5.5 Takeda Key News
7.6 Vanda Pharmaceuticals
7.6.1 Vanda Pharmaceuticals Corporate Summary
7.6.2 Vanda Pharmaceuticals Business Overview
7.6.3 Vanda Pharmaceuticals Insomnia Medication Major Product Offerings
7.6.4 Vanda Pharmaceuticals Insomnia Medication Sales and Revenue in Global (2017-2022)
7.6.5 Vanda Pharmaceuticals Key News
7.7 Astellas
7.7.1 Astellas Corporate Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Insomnia Medication Major Product Offerings
7.7.4 Astellas Insomnia Medication Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Key News
7.8 Dainippon Sumitomo
7.8.1 Dainippon Sumitomo Corporate Summary
7.8.2 Dainippon Sumitomo Business Overview
7.8.3 Dainippon Sumitomo Insomnia Medication Major Product Offerings
7.8.4 Dainippon Sumitomo Insomnia Medication Sales and Revenue in Global (2017-2022)
7.8.5 Dainippon Sumitomo Key News
7.9 ECR Pharmaceuticals (Valeant)
7.9.1 ECR Pharmaceuticals (Valeant) Corporate Summary
7.9.2 ECR Pharmaceuticals (Valeant) Business Overview
7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Major Product Offerings
7.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales and Revenue in Global (2017-2022)
7.9.5 ECR Pharmaceuticals (Valeant) Key News
7.10 Flynn Pharma
7.10.1 Flynn Pharma Corporate Summary
7.10.2 Flynn Pharma Business Overview
7.10.3 Flynn Pharma Insomnia Medication Major Product Offerings
7.10.4 Flynn Pharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.10.5 Flynn Pharma Key News
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporate Summary
7.11.2 Johnson & Johnson Insomnia Medication Business Overview
7.11.3 Johnson & Johnson Insomnia Medication Major Product Offerings
7.11.4 Johnson & Johnson Insomnia Medication Sales and Revenue in Global (2017-2022)
7.11.5 Johnson & Johnson Key News
7.12 Meda
7.12.1 Meda Corporate Summary
7.12.2 Meda Insomnia Medication Business Overview
7.12.3 Meda Insomnia Medication Major Product Offerings
7.12.4 Meda Insomnia Medication Sales and Revenue in Global (2017-2022)
7.12.5 Meda Key News
7.13 Somnus Therapeutics
7.13.1 Somnus Therapeutics Corporate Summary
7.13.2 Somnus Therapeutics Insomnia Medication Business Overview
7.13.3 Somnus Therapeutics Insomnia Medication Major Product Offerings
7.13.4 Somnus Therapeutics Insomnia Medication Sales and Revenue in Global (2017-2022)
7.13.5 Somnus Therapeutics Key News
7.14 Purdue Pharma
7.14.1 Purdue Pharma Corporate Summary
7.14.2 Purdue Pharma Business Overview
7.14.3 Purdue Pharma Insomnia Medication Major Product Offerings
7.14.4 Purdue Pharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.14.5 Purdue Pharma Key News
7.15 Neurim
7.15.1 Neurim Corporate Summary
7.15.2 Neurim Business Overview
7.15.3 Neurim Insomnia Medication Major Product Offerings
7.15.4 Neurim Insomnia Medication Sales and Revenue in Global (2017-2022)
7.15.5 Neurim Key News
7.16 Minerva Neurosciences
7.16.1 Minerva Neurosciences Corporate Summary
7.16.2 Minerva Neurosciences Business Overview
7.16.3 Minerva Neurosciences Insomnia Medication Major Product Offerings
7.16.4 Minerva Neurosciences Insomnia Medication Sales and Revenue in Global (2017-2022)
7.16.5 Minerva Neurosciences Key News
7.17 Pernix Therapeutics
7.17.1 Pernix Therapeutics Corporate Summary
7.17.2 Pernix Therapeutics Business Overview
7.17.3 Pernix Therapeutics Insomnia Medication Major Product Offerings
7.17.4 Pernix Therapeutics Insomnia Medication Sales and Revenue in Global (2017-2022)
7.17.5 Pernix Therapeutics Key News
7.18 SkyePharma
7.18.1 SkyePharma Corporate Summary
7.18.2 SkyePharma Business Overview
7.18.3 SkyePharma Insomnia Medication Major Product Offerings
7.18.4 SkyePharma Insomnia Medication Sales and Revenue in Global (2017-2022)
7.18.5 SkyePharma Key News
7.19 Paratek Pharmaceuticals
7.19.1 Paratek Pharmaceuticals Corporate Summary
7.19.2 Paratek Pharmaceuticals Business Overview
7.19.3 Paratek Pharmaceuticals Insomnia Medication Major Product Offerings
7.19.4 Paratek Pharmaceuticals Insomnia Medication Sales and Revenue in Global (2017-2022)
7.19.5 Paratek Pharmaceuticals Key News
8 GLOBAL INSOMNIA MEDICATION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insomnia Medication Production Capacity, 2017-2028
8.2 Insomnia Medication Production Capacity of Key Manufacturers in Global Market
8.3 Global Insomnia Medication Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSOMNIA MEDICATION SUPPLY CHAIN ANALYSIS
10.1 Insomnia Medication Industry Value Chain
10.2 Insomnia Medication Upstream Market
10.3 Insomnia Medication Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insomnia Medication Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Insomnia Medication in Global Market
Table 2. Top Insomnia Medication Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Insomnia Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Insomnia Medication Revenue Share by Companies, 2017-2022
Table 5. Global Insomnia Medication Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Insomnia Medication Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Insomnia Medication Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Insomnia Medication Product Type
Table 9. List of Global Tier 1 Insomnia Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insomnia Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 15. By Type - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 16. By Application – Global Insomnia Medication Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 20. By Application - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 21. By Region – Global Insomnia Medication Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 25. By Region - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 26. By Country - North America Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Insomnia Medication Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Insomnia Medication Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Insomnia Medication Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Insomnia Medication Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Insomnia Medication Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Insomnia Medication Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Insomnia Medication Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Insomnia Medication Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Insomnia Medication Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Insomnia Medication Sales, (K Pcs), 2023-2028
Table 46. Eisai Corporate Summary
Table 47. Eisai Insomnia Medication Product Offerings
Table 48. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Insomnia Medication Product Offerings
Table 51. Merck Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Insomnia Medication Product Offerings
Table 54. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Insomnia Medication Product Offerings
Table 57. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Takeda Corporate Summary
Table 59. Takeda Insomnia Medication Product Offerings
Table 60. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Vanda Pharmaceuticals Corporate Summary
Table 62. Vanda Pharmaceuticals Insomnia Medication Product Offerings
Table 63. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Astellas Corporate Summary
Table 65. Astellas Insomnia Medication Product Offerings
Table 66. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Dainippon Sumitomo Corporate Summary
Table 68. Dainippon Sumitomo Insomnia Medication Product Offerings
Table 69. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. ECR Pharmaceuticals (Valeant) Corporate Summary
Table 71. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
Table 72. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Flynn Pharma Corporate Summary
Table 74. Flynn Pharma Insomnia Medication Product Offerings
Table 75. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Johnson & Johnson Corporate Summary
Table 77. Johnson & Johnson Insomnia Medication Product Offerings
Table 78. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Meda Corporate Summary
Table 80. Meda Insomnia Medication Product Offerings
Table 81. Meda Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Somnus Therapeutics Corporate Summary
Table 83. Somnus Therapeutics Insomnia Medication Product Offerings
Table 84. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Purdue Pharma Corporate Summary
Table 86. Purdue Pharma Insomnia Medication Product Offerings
Table 87. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Neurim Corporate Summary
Table 89. Neurim Insomnia Medication Product Offerings
Table 90. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Minerva Neurosciences Corporate Summary
Table 92. Minerva Neurosciences Insomnia Medication Product Offerings
Table 93. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Pernix Therapeutics Corporate Summary
Table 95. Pernix Therapeutics Insomnia Medication Product Offerings
Table 96. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. SkyePharma Corporate Summary
Table 98. SkyePharma Insomnia Medication Product Offerings
Table 99. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Paratek Pharmaceuticals Corporate Summary
Table 101. Paratek Pharmaceuticals Insomnia Medication Product Offerings
Table 102. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Insomnia Medication Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 104. Global Insomnia Medication Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Insomnia Medication Production by Region, 2017-2022 (K Pcs)
Table 106. Global Insomnia Medication Production by Region, 2023-2028 (K Pcs)
Table 107. Insomnia Medication Market Opportunities & Trends in Global Market
Table 108. Insomnia Medication Market Drivers in Global Market
Table 109. Insomnia Medication Market Restraints in Global Market
Table 110. Insomnia Medication Raw Materials
Table 111. Insomnia Medication Raw Materials Suppliers in Global Market
Table 112. Typical Insomnia Medication Downstream
Table 113. Insomnia Medication Downstream Clients in Global Market
Table 114. Insomnia Medication Distributors and Sales Agents in Global Market
Table 1. Key Players of Insomnia Medication in Global Market
Table 2. Top Insomnia Medication Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Insomnia Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Insomnia Medication Revenue Share by Companies, 2017-2022
Table 5. Global Insomnia Medication Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Insomnia Medication Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Insomnia Medication Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Insomnia Medication Product Type
Table 9. List of Global Tier 1 Insomnia Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insomnia Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 15. By Type - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 16. By Application – Global Insomnia Medication Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 20. By Application - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 21. By Region – Global Insomnia Medication Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Insomnia Medication Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Insomnia Medication Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Insomnia Medication Sales (K Pcs), 2017-2022
Table 25. By Region - Global Insomnia Medication Sales (K Pcs), 2023-2028
Table 26. By Country - North America Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Insomnia Medication Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Insomnia Medication Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Insomnia Medication Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Insomnia Medication Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Insomnia Medication Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Insomnia Medication Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Insomnia Medication Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Insomnia Medication Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Insomnia Medication Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Insomnia Medication Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Insomnia Medication Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Insomnia Medication Sales, (K Pcs), 2023-2028
Table 46. Eisai Corporate Summary
Table 47. Eisai Insomnia Medication Product Offerings
Table 48. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Insomnia Medication Product Offerings
Table 51. Merck Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Insomnia Medication Product Offerings
Table 54. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Insomnia Medication Product Offerings
Table 57. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Takeda Corporate Summary
Table 59. Takeda Insomnia Medication Product Offerings
Table 60. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Vanda Pharmaceuticals Corporate Summary
Table 62. Vanda Pharmaceuticals Insomnia Medication Product Offerings
Table 63. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Astellas Corporate Summary
Table 65. Astellas Insomnia Medication Product Offerings
Table 66. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Dainippon Sumitomo Corporate Summary
Table 68. Dainippon Sumitomo Insomnia Medication Product Offerings
Table 69. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. ECR Pharmaceuticals (Valeant) Corporate Summary
Table 71. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
Table 72. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Flynn Pharma Corporate Summary
Table 74. Flynn Pharma Insomnia Medication Product Offerings
Table 75. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Johnson & Johnson Corporate Summary
Table 77. Johnson & Johnson Insomnia Medication Product Offerings
Table 78. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Meda Corporate Summary
Table 80. Meda Insomnia Medication Product Offerings
Table 81. Meda Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Somnus Therapeutics Corporate Summary
Table 83. Somnus Therapeutics Insomnia Medication Product Offerings
Table 84. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Purdue Pharma Corporate Summary
Table 86. Purdue Pharma Insomnia Medication Product Offerings
Table 87. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Neurim Corporate Summary
Table 89. Neurim Insomnia Medication Product Offerings
Table 90. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Minerva Neurosciences Corporate Summary
Table 92. Minerva Neurosciences Insomnia Medication Product Offerings
Table 93. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Pernix Therapeutics Corporate Summary
Table 95. Pernix Therapeutics Insomnia Medication Product Offerings
Table 96. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. SkyePharma Corporate Summary
Table 98. SkyePharma Insomnia Medication Product Offerings
Table 99. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Paratek Pharmaceuticals Corporate Summary
Table 101. Paratek Pharmaceuticals Insomnia Medication Product Offerings
Table 102. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Insomnia Medication Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 104. Global Insomnia Medication Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Insomnia Medication Production by Region, 2017-2022 (K Pcs)
Table 106. Global Insomnia Medication Production by Region, 2023-2028 (K Pcs)
Table 107. Insomnia Medication Market Opportunities & Trends in Global Market
Table 108. Insomnia Medication Market Drivers in Global Market
Table 109. Insomnia Medication Market Restraints in Global Market
Table 110. Insomnia Medication Raw Materials
Table 111. Insomnia Medication Raw Materials Suppliers in Global Market
Table 112. Typical Insomnia Medication Downstream
Table 113. Insomnia Medication Downstream Clients in Global Market
Table 114. Insomnia Medication Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Insomnia Medication Segment by Type
Figure 2. Insomnia Medication Segment by Application
Figure 3. Global Insomnia Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insomnia Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insomnia Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. Insomnia Medication Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Insomnia Medication Revenue in 2021
Figure 9. By Type - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 10. By Type - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 11. By Type - Global Insomnia Medication Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 13. By Application - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 14. By Application - Global Insomnia Medication Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 16. By Region - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 17. By Country - North America Insomnia Medication Revenue Market Share, 2017-2028
Figure 18. By Country - North America Insomnia Medication Sales Market Share, 2017-2028
Figure 19. US Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Insomnia Medication Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Insomnia Medication Sales Market Share, 2017-2028
Figure 24. Germany Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 25. France Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Insomnia Medication Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Insomnia Medication Sales Market Share, 2017-2028
Figure 33. China Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 37. India Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Insomnia Medication Revenue Market Share, 2017-2028
Figure 39. By Country - South America Insomnia Medication Sales Market Share, 2017-2028
Figure 40. Brazil Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Insomnia Medication Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Insomnia Medication Sales Market Share, 2017-2028
Figure 44. Turkey Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 48. Global Insomnia Medication Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Insomnia Medication by Region, 2021 VS 2028
Figure 50. Insomnia Medication Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Insomnia Medication Segment by Type
Figure 2. Insomnia Medication Segment by Application
Figure 3. Global Insomnia Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insomnia Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insomnia Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. Insomnia Medication Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Insomnia Medication Revenue in 2021
Figure 9. By Type - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 10. By Type - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 11. By Type - Global Insomnia Medication Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 13. By Application - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 14. By Application - Global Insomnia Medication Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Insomnia Medication Sales Market Share, 2017-2028
Figure 16. By Region - Global Insomnia Medication Revenue Market Share, 2017-2028
Figure 17. By Country - North America Insomnia Medication Revenue Market Share, 2017-2028
Figure 18. By Country - North America Insomnia Medication Sales Market Share, 2017-2028
Figure 19. US Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Insomnia Medication Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Insomnia Medication Sales Market Share, 2017-2028
Figure 24. Germany Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 25. France Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Insomnia Medication Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Insomnia Medication Sales Market Share, 2017-2028
Figure 33. China Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 37. India Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Insomnia Medication Revenue Market Share, 2017-2028
Figure 39. By Country - South America Insomnia Medication Sales Market Share, 2017-2028
Figure 40. Brazil Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Insomnia Medication Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Insomnia Medication Sales Market Share, 2017-2028
Figure 44. Turkey Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Insomnia Medication Revenue, (US$, Mn), 2017-2028
Figure 48. Global Insomnia Medication Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Insomnia Medication by Region, 2021 VS 2028
Figure 50. Insomnia Medication Industry Value Chain
Figure 51. Marketing Channels
